Inlyta 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FGRXW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,896
Award facts
- Contract value 100% obligated
- $11,895.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INLYTA 5 mg tablets (60-count) valued at $11.9K under a firm fixed-price contract type. This delivery order, issued on October 22, 2025, with an ultimate completion date of November 13, 2025, represents a non-competitive set-aside award for pharmaceutical procurement to support federal medical supply needs. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains operations as a major pharmaceutical distributor serving the Defense Health System.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products, specialty medications, generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio reflects its critical role in the pharmaceutical supply chain for military and veteran healthcare systems, with consistent delivery of competitive, firm fixed-price orders across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FGRXW?
SPE2DB26FGRXW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FGRXW worth?
The government has obligated $11,896 on SPE2DB26FGRXW.
Is contract SPE2DB26FGRXW an order under another contract?
Yes. SPE2DB26FGRXW is a delivery order under SPE2DB24D2215, an indefinite delivery contract.
Was contract SPE2DB26FGRXW competed?
The extent of competition for SPE2DB26FGRXW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award